This Course has been CANCELLED.
Canadian Respiratory Conference is organized by the Canadian Thoracic Society (CTS) / Societe Canadienne de thoracologie (SCT). The session commences from Apr 16 – 18, 2020 at Niagara Falls, Ontario, Canada.
Session Description
This session will evaluate the pathogenesis of TB and the rationale for the treatment of latent TB. Diagnosis and supervision, including the concept of a cascade of care in latent TB, will be presented. The treatment of latent TB, including the current standard of INH for six-nine months, three to four months INH & Rifampin and three months INH & Rifapentine will be examined. Finally, two recent trials of four months Rifampin will be discussed. The lecture will end with a comparison of the different treatment options and the rationale for passing on from INH to some Rifamycin-based treatments.
Learning Objectives
By the end of the session, attendees will be able to:
• Know the rationale for treatment of latent TB;
• Perceive the different treatment options for latent TB and their benefits and drawbacks; and
• Understand why we need to stop using INH as our standard treatment and move on to rifampin or rifapentine–based regimen.
Additional details will be posted as soon as they are available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved